TAKARA BIO INC.(4974) News

Notice Regarding Cancellation of Treasury Stock

Notice about Share Consolidation, Abolition of the Provision on Share Units and Partial Amendment of the Articles of Incorporation

Announcement of Results of the Tender Offer by Takara Holdings, the Parent Company of the Company, for the Common Stock of the Company

Notice Regarding Setting of Record Date for Convocation of Extraordinary General Shareholders’ Meeting

(Summary) Notice Concerning Expression of Opinion in Support of Tender Offer for Company Shares by Takara Holdings, and Recommendation to Tender Share

Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP)

TAKARA BIO, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens

[Correction] Notice Concerning Revisions to Notice Concerning Revisions to the Financial Results Forecasts and Dividend Forecasts (No dividends) and P

TAKARA BIO, Ordinary Profit Forecast for the Fiscal Year Revised Downward to a Loss, Dividend Dividend Also Turns into No Dividend

Notice Concerning Revisions to the Financial Results Forecasts and Dividend Forecasts (No dividends) and Partial Return of Executive Remuneration

Consolidated Financial Results for the Six Months Ended September 30, 2025

Notice Concerning Revisions to Financial Results Forecasts for the First Half, Recognition of Extraordinary Loss, and Reversal of Deferred Tax Assets

TAKARA BIO, Net Income Forecast for First Half Loss Widened in Downward Revision

TAKARA BIO, Apr-Jun (1Q) Ordinary Profit Loss Widens

Consolidated Financial Results for the Three Months Ended June 30, 2025 (Under Japanese GAAP)

Matters Concerning Controlling Shareholders

Notice of Changes in Representative Directors

Notice Concerning Dividend from Surplus

Consolidated Financial Results for the FY Ended March 31 2025

TAKARA BIO, 4% Decrease in Ordinary Profit for The Current Fiscal Year